In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, which has been the standard treatment. A resorbable scaffold is a stent-like structure that props the artery open but is biodegradable and dissolves within a few years, avoiding some of the potential complications of a permanent stent.

The researchers compared the insertion of a resorbable scaffold — imbued with a drug to reduce the chance of reblockage — to standard angioplasty in 261 patients with severe artery disease below the knee. They found that 74 percent of the patients who received the resorbable scaffold avoided a bad outcome such as leg amputation or new artery-opening intervention in the year after the procedure, compared with 44 percent of patients who underwent angioplasty.

Resorbable scaffolds that slowly release inflammation-suppressing compounds are already used to treat coronary artery blockages, and some initial studies have suggested that they might be more effective than angioplasty for lower-leg artery disease. Scaffolds provide direct mechanical support to diseased arteries for much longer, compared to angioplasty. They also dissolve eventually, unlike permanent stents which can accelerate artery re-blockage by their long-term contact with artery walls and can complicate future interventions.

Scaffold insertion also appeared to be as safe as angioplasty, in terms of procedure-related complications. (Image credit: Shutterstock)

For more information, visit here  .



Magazine cover
Medical Design Briefs Magazine

This article first appeared in the January, 2024 issue of Medical Design Briefs Magazine (Vol. 14 No. 1).

Read more articles from this issue here.

Read more articles from the archives here.